107 related articles for article (PubMed ID: 8995163)
1. Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome.
Dinger J; Schwarze R; Rupprecht E
Pediatr Radiol; 1997 Jan; 27(1):26-31. PubMed ID: 8995163
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic use of surfactant in neonatal respiratory distress syndrome. Correlation between pulmonary X-ray changes and clinical data.
Bick U; Müller-Leisse C; Tröger J; Jorch G; Roos N; Meyer zu Wendischhoff J; Flothmann U; Kachel W; Lemburg P; Linderkamp O
Pediatr Radiol; 1992; 22(3):169-73. PubMed ID: 1508581
[TBL] [Abstract][Full Text] [Related]
3. Findings on chest radiographs after prophylactic pulmonary surfactant treatment of premature infants.
Clarke EA; Siegle RL; Gong AK
AJR Am J Roentgenol; 1989 Oct; 153(4):799-802. PubMed ID: 2773736
[TBL] [Abstract][Full Text] [Related]
4. The significance of recurrent lung opacities in neonates on surfactant treatment for respiratory distress syndrome.
Odita JC
Pediatr Radiol; 2001 Feb; 31(2):87-91. PubMed ID: 11214692
[TBL] [Abstract][Full Text] [Related]
5. Respiratory distress syndrome treated with human surfactant: radiographic findings.
Edwards DK; Hilton SV; Merritt TA; Hallman M; Mannino F; Boynton BR
Radiology; 1985 Nov; 157(2):329-34. PubMed ID: 3840268
[TBL] [Abstract][Full Text] [Related]
6. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
Chen A; Shi LP; Zheng JY; Du LZ
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
[TBL] [Abstract][Full Text] [Related]
8. Chronic lung disease of the very low birth weight infant--is it preventable?
Ogawa Y
Turk J Pediatr; 1998; 40(1):35-44. PubMed ID: 9673527
[TBL] [Abstract][Full Text] [Related]
9. Severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant.
Noack G; Berggren P; Curstedt T; Grossmann G; Herin P; Mortensson W; Nilsson R; Robertson B
Acta Paediatr Scand; 1987 Sep; 76(5):697-705. PubMed ID: 3661171
[TBL] [Abstract][Full Text] [Related]
10. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
[TBL] [Abstract][Full Text] [Related]
11. Chest radiographic course after exogenous surfactant therapy in baboons with respiratory distress syndrome.
Shimada S; Raju TN; Vidyasagar D; Maeta H; Bhat R
Crit Care Med; 1990 Sep; 18(9):969-73. PubMed ID: 2394121
[TBL] [Abstract][Full Text] [Related]
12. Lung ultrasonography score versus chest X-ray score to predict surfactant administration in newborns with respiratory distress syndrome.
Perri A; Riccardi R; Iannotta R; Di Molfetta DV; Arena R; Vento G; Zecca E
Pediatr Pulmonol; 2018 Sep; 53(9):1231-1236. PubMed ID: 29870158
[TBL] [Abstract][Full Text] [Related]
13. Exogenous lung surfactant: effect on radiographic appearance in premature infants.
Wood BP; Sinkin RA; Kendig JW; Notter RH; Shapiro DL
Radiology; 1987 Oct; 165(1):11-3. PubMed ID: 3306780
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome.
Cochrane CG; Revak SD; Merritt TA; Heldt GP; Hallman M; Cunningham MD; Easa D; Pramanik A; Edwards DK; Alberts MS
Am J Respir Crit Care Med; 1996 Jan; 153(1):404-10. PubMed ID: 8542150
[TBL] [Abstract][Full Text] [Related]
15. Radiologic observations in severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant.
Mortensson W; Noack G; Curstedt T; Herin P; Robertson B
Acta Radiol; 1987; 28(4):389-94. PubMed ID: 2958051
[TBL] [Abstract][Full Text] [Related]
16. Radiological analysis of hyaline membrane disease after exogenous surfactant treatment.
Slama M; André C; Huon C; Antoun H; Adamsbaum C
Pediatr Radiol; 1999 Jan; 29(1):56-60. PubMed ID: 9880619
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
18. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao.
Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD
West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907
[TBL] [Abstract][Full Text] [Related]
19. [Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].
Speer CP; Harms K; Herting E; Müller F; Schröter W; Teichmann AT; Neumann N; Curstedt T; Robertson B
Geburtshilfe Frauenheilkd; 1990 May; 50(5):359-64. PubMed ID: 2197165
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
